Biomarin Pharmaceutical Inc
F:BM8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biomarin Pharmaceutical Inc
F:BM8
|
US |
|
Sherritt International Corp
TSX:S
|
CA |
Wall St Price Targets
BM8 Price Targets Summary
Biomarin Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for BM8 is 66.71 EUR with a low forecast of 42.61 EUR and a high forecast of 93.1 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BM8's stock price target?
Price Target
66.71
EUR
According to Wall Street analysts, the average 1-year price target for BM8 is 66.71 EUR with a low forecast of 42.61 EUR and a high forecast of 93.1 EUR.
What is the Revenue forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Gross Profit forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
14%
The compound annual growth rate for Operating Income over the next 8 years is 14%.
What is the Pre-Tax Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
51%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 51%.
What is the Net Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
24%
The compound annual growth rate for Net Income over the next 8 years is 24%.
